Our Goal: Gabrielle’s Angel Foundation funds the nation’s best science in the fields of leukemia, lymphoma, and related cancers of the blood. The Foundation not only funds conventional scientific research, but also projects that combine integrative (complementary) therapies or botanical agents. We focus on projects for cancer prevention, detection and treatment that are most likely to be translated into clinical trials within a 3 – 5 year period. These Medical Research Awards, distributed on a yearly basis, each total $225,000.00 and are given over a three-year period. The top research institutions in the nation are solicited by invitation-only and, once the applications are received, undergo rigorous peer review by the Foundation’s ten-member Medical Advisory Board. This panel of experts, led by Stephen D. Nimer, M.D. of New York’s Memorial Sloan-Kettering Cancer Center, selects only the crème de la crème for funding. 67% of our grantees are able to obtain further funding at the federal level thanks to their early career support from Gabrielle’s Angel Foundation. In recent years, the Foundation has expanded its reach to include the funding of select pediatric oncology initiatives, music therapy programs, and international projects. Gabrielle’s Angel Foundation has supported more than 80 of the country’s leading junior investigators totaling over $16 million and maintains its status as one of the nation’s largest non-governmental sources of grant support for blood cancer research.
Statements on this website have not been evaluated by the Food and Drug Administration. None of the products / services offered on this Web site are intended to diagnose, treat, cure or prevent any disease.